Insider Shareholders with Direct Ownership of Quoin Pharmaceuticals, Ltd. (QNRX)
This section provides a comprehensive overview of the insiders with direct ownership of Quoin Pharmaceuticals, Ltd. (QNRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Quoin Pharmaceuticals, Ltd. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Michael Myers
Chief Executive Officer |
593,450 | 0 | 602,808 $427,993 | 3 |
Dec 23, 2024
Added 47.96%
|
|
Denise P. Carter
Chief Operating Officer |
593,291 | 0 | 602,648 $427,880 | 3 |
Dec 23, 2024
Added 47.97%
|
|
Gordon Dunn
Chief Financial Officer |
151,077 | 0 | 151,077 $107,264 | 3 |
Dec 23, 2024
Added 44.72%
|
|
Anthony James Culverwell
Director |
100,000 | 0 | 100,317 $71,225 | 1 |
Dec 23, 2024
Added 49.92%
|
|
Dennis Langer
Director |
0 | 297 | 53 $37 | 1 |
Jun 07, 2024
Reduced 84.86%
|